Today: 13 April 2026
Browse Category

Stock Market 6 April 2026 - 7 April 2026

Sensex Today: Nifty Tops 23,100 as IT Stocks Lift India Shares Ahead of RBI Decision

Sensex Today: Nifty Tops 23,100 as IT Stocks Lift India Shares Ahead of RBI Decision

The Nifty 50 closed up 0.68% at 23,123.65 and the Sensex gained 510 points as IT stocks rallied ahead of earnings. Fourteen of 16 sectors advanced, led by Wipro, TCS, HCLTech, and Infosys. Hindalco and Vedanta rose after JPMorgan upgrades. The rupee strengthened to 93.0075 per dollar, but foreign investors pulled nearly $16 billion from Indian equities in March and April.
Hologic Buyout Nears Close After Final Approvals in Blackstone-TPG Deal; CEO Steve MacMillan to Retire

Hologic Buyout Nears Close After Final Approvals in Blackstone-TPG Deal; CEO Steve MacMillan to Retire

Hologic said it has secured all regulatory approvals for its $18.3 billion sale to Blackstone and TPG, with closing expected on or about April 7. CEO Steve MacMillan will retire at closing. Nasdaq will halt trading in Hologic shares after Monday’s session and suspend them effective April 8. S&P Dow Jones Indices will remove Hologic from the S&P 500 before the open on April 9.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 07.04.2026

LIVEMarkets rolling coverageStarted: April 7, 2026, 12:00 AM EDTUpdated: April 7, 2026, 11:58 PM EDT Boston Scientific (BSX) Shares Hit 45% Discount; Undervalued Despite 34.7% YTD Drop April 7, 2026, 11:58 PM EDT. Boston Scientific's (BSX) share price has fallen 34.7% year to date, now trading around $61.86, down 31.8% over the past year. Despite this pullback, a discounted cash flow (DCF) analysis values the stock at approximately $112.50, suggesting a 45% undervaluation. Free cash flow forecasts rise from $3.63 billion to $6.84 billion by 2029, underpinning the bullish DCF outlook. The stock trades at a price-to-earnings (P/E) ratio of
7 April 2026
Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Neurocrine Biosciences will acquire Soleno Therapeutics for $53 a share in cash, valuing Soleno at $2.9 billion. The deal gives Neurocrine Vykat XR, the only FDA-approved treatment for hyperphagia in Prader-Willi syndrome. Soleno shares last traded at $52.25. The transaction is expected to close within 90 days, pending regulatory and shareholder approval.
Stock Market Today: Dow, S&P 500, Nasdaq Rise on Iran Ceasefire Hopes; Oil Above $110, Seagate Surges, Tesla Falls

Stock Market Today: Dow, S&P 500, Nasdaq Rise on Iran Ceasefire Hopes; Oil Above $110, Seagate Surges, Tesla Falls

The Dow rose 165 points Monday as the S&P 500 and Nasdaq marked a fourth consecutive gain. Brent crude settled at $109.77 and WTI at $112.40 amid uncertainty over Iran ceasefire talks. Seagate shares jumped after a Morgan Stanley upgrade, while Tesla fell on delivery and cash-flow concerns. Futures stayed near flat ahead of President Trump’s Tuesday deadline on Iran.
Hologic CEO Steve MacMillan to Retire as Blackstone, TPG Near $18.3 Billion Buyout Close

Hologic CEO Steve MacMillan to Retire as Blackstone, TPG Near $18.3 Billion Buyout Close

Hologic said CEO Steve MacMillan will retire when its $18.3 billion sale to Blackstone and TPG closes, expected April 7 after all regulatory approvals. Nasdaq plans to halt Hologic shares after trading April 6 and suspend them April 8. Shareholders get $76 per share in cash plus a contingent value right tied to Breast Health revenue targets. The next CEO will be named after the deal closes.
Oklo stock: insider-sale filings point to about $11 million, not $21 million, after earnings miss

Oklo stock: insider-sale filings point to about $11 million, not $21 million, after earnings miss

Oklo co-founders Jacob DeWitte and Caroline Cochran reported April 1 stock sales totaling about $10.1 million, not $21 million as some summaries stated, according to SEC filings. CFO Richard Bealmear sold $834,000 in shares after exercising options. Oklo shares traded at $48.76 Monday. The company reported no 2025 revenue and a $105.7 million net loss.
UnitedHealth Stock Gets Lift Ahead of Q1 Earnings After Medicare Advantage Rate Boost

UnitedHealth Stock Gets Lift Ahead of Q1 Earnings After Medicare Advantage Rate Boost

U.S. officials approved a 2.48% increase in 2027 Medicare Advantage rates Monday, sending UnitedHealth Group shares higher after months of pressure. The move adds over $13 billion to plan payments, exceeding analyst expectations. UnitedHealth reports first-quarter results April 21, with analysts forecasting an 8% earnings drop from last year. CMS kept tighter risk-adjustment rules despite the higher rates.
Mortgage Rates Today: 30-Year Fixed Dips to 6.43%, but Spring Buyers Get Little Relief

Mortgage Rates Today: 30-Year Fixed Dips to 6.43%, but Spring Buyers Get Little Relief

U.S. mortgage rates edged down Monday, with Mortgage News Daily reporting the average 30-year fixed at 6.43%, down 0.02 percentage point. Purchase applications fell 3% last week, according to the Mortgage Bankers Association. Redfin said the median monthly mortgage payment reached $2,742, the first year-over-year rise in nearly six months. Analysts expect rates to stay elevated amid economic uncertainty and Middle East tensions.
Dow Jones Today: Industrial Average Rises as Iran Ceasefire Hopes Offset Oil and Fed Fears

Dow Jones Today: Industrial Average Rises as Iran Ceasefire Hopes Offset Oil and Fed Fears

The Dow Jones rose 83.20 points to 46,587.48 by midday Monday as hopes for Iran ceasefire talks steadied Wall Street. JPMorgan Chase and Visa led gains, while oil stayed above $110 a barrel and services PMI slipped to 54.0. Iran rejected a ceasefire, and President Trump set a Tuesday deadline to reopen the Strait of Hormuz. Trading was lighter due to holidays in Europe and Asia.
US Stock Market Today: Dow, S&P 500 and Nasdaq Rise as Iran Ceasefire Hopes Clash With Inflation Fears

US Stock Market Today: Dow, S&P 500 and Nasdaq Rise as Iran Ceasefire Hopes Clash With Inflation Fears

U.S. stocks rose Monday, with the Dow up 83 points by midday as reports of new Iran ceasefire talks lifted sentiment. Oil hovered near $111 a barrel amid Middle East tensions and a looming deadline from Trump on Iran. The ISM services PMI fell to 54.0 in March, while payrolls rose 178,000 and unemployment dropped to 4.3%. Wells Fargo and Citigroup delayed expectations for Federal Reserve rate cuts.
JPMorgan Stock Price Targets Reset as Evercore Cuts to $320, Piper Holds Overweight

JPMorgan Stock Price Targets Reset as Evercore Cuts to $320, Piper Holds Overweight

Evercore ISI cut its JPMorgan Chase price target to $320 from $350 on Monday, while the stock traded at $296.06 midday. CEO Jamie Dimon warned in his annual letter that war in Iran could trigger oil shocks, higher inflation, and interest rates. JPMorgan reported record annual revenue of $185.6 billion and net income of $57 billion. Wall Street targets now range from the low $320s to $365.
6 April 2026
Palantir Stock (PLTR) Splits Opinion as Bulls Eye $1 Trillion and Bears Warn of Sub-$100 Drop

Palantir Stock (PLTR) Splits Opinion as Bulls Eye $1 Trillion and Bears Warn of Sub-$100 Drop

Palantir Technologies traded near $148 midday Monday, down about 30% from its record high, with a market value of $433 billion. Motley Fool and Seeking Alpha analysts split on the stock’s outlook, with targets ranging from below $100 to $221.86. Recent Pentagon moves to formalize Project Maven and surging government sales have fueled bullish arguments. Benchmark and eToro analysts urged caution on valuation.
6 April 2026
Sandisk Stock Jumps Again as AI Storage Demand Defies S&P 500 Slump

Sandisk Stock Jumps Again as AI Storage Demand Defies S&P 500 Slump

Sandisk shares rose 2.8% to $720.90 in late-morning New York trading Monday, outpacing the S&P 500’s 0.2% gain. The company reported fiscal Q2 revenue up 61% to $3.03 billion and forecast Q3 revenue above analyst estimates. Sandisk extended its joint venture with Kioxia through 2034 for $1.165 billion. Micron, Western Digital, and Seagate also advanced.
Pfizer Stock Faces Fresh Questions as Aberdeen, Stratos and Raab & Moskowitz Trim Stakes

Pfizer Stock Faces Fresh Questions as Aberdeen, Stratos and Raab & Moskowitz Trim Stakes

Aberdeen Group, Raab & Moskowitz Asset Management, and Stratos Wealth Partners sold a combined 740,174 Pfizer shares in the fourth quarter, according to recent 13F filings. Pfizer stock traded down 0.7% at $28.12 Monday. The three firms still held about $140.9 million in Pfizer shares at year-end. Pfizer halted a major U.S. COVID shot study after the period covered by the filings.
Lumentum Back in Focus Ahead of Earnings as AI Optics Bottleneck Trade Gathers Pace

Lumentum Back in Focus Ahead of Earnings as AI Optics Bottleneck Trade Gathers Pace

Lumentum Holdings will report fiscal Q3 results on May 5. Shares fell 1.3% after recent gains tied to Nvidia’s $2 billion investment and purchase commitment for advanced laser components. Fiscal Q2 revenue rose to $665.5 million from $402.2 million a year earlier, driven by demand for optical circuit switches. Lumentum recently acquired a North Carolina facility to expand optical device production.
SCHD Draws Fresh Attention After New Dividend and 2026 Reconstitution

SCHD Draws Fresh Attention After New Dividend and 2026 Reconstitution

Schwab U.S. Dividend Equity ETF paid a $0.2569 per-share dividend for March, up 3.3% from last year, and finished a major reshuffle in its annual index reset. SCHD drew $4 billion in Q1 inflows as U.S. dividend funds saw their strongest start since 2020. The fund now holds 104 stocks, with Chevron and ConocoPhillips still its largest positions. Health care and tech exposure rose, while energy and materials fell.
Boeing Stock Faces a Make-or-Break Test as Backlog Strength Collides With Safety Fears

Boeing Stock Faces a Make-or-Break Test as Backlog Strength Collides With Safety Fears

Boeing shares rose 1.4% Monday as analysts split over the stock ahead of first-quarter results due April 22. Bulls cited record backlog and a new Pentagon missile deal; bears pointed to safety concerns, debt, and weak cash flow. Boeing reported $89.5 billion in 2025 revenue but ended the year with $1.9 billion negative free cash flow and $54.1 billion in debt. Production discipline, not demand, is seen as the key risk.
6 April 2026
IBM Stock Faces April 22 Earnings Test as AI Deals Meet Wall Street Doubts

IBM Stock Faces April 22 Earnings Test as AI Deals Meet Wall Street Doubts

IBM shares fell 0.7% to $246.43 Monday despite announcing a new AI project with Tata Play Fiber in India. Investors remain focused on IBM’s April 22 earnings report after a February selloff triggered by concerns over mainframe demand and competition from Anthropic’s Claude Code tool. IBM’s stock remains well below its 52-week high of $324.90.

Stock Market Today

  • Dell and HP Shares Surge on Nvidia Acquisition Speculation
    April 13, 2026, 3:00 PM EDT. Shares of Dell Technologies and HP Inc. jumped sharply after reports that Nvidia Corp. is considering acquiring a major PC vendor to reshape the industry. Nvidia, the top chipmaker for artificial intelligence (AI), has been negotiating a large purchase for over a year. Dell holds about 17% of the global PC market, HP nearly 19%, according to Gartner. Nvidia has invested $70 billion to advance AI across sectors and Dell projects $50 billion in revenue from AI servers using Nvidia chips by January 2027. Dell shares rose 6.3% to $188.95 while HP climbed 2.3% to $18.68. Neither company commented on the rumored talks.

Latest article

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

13 April 2026
Marvell Technology shares rose 2.1% to $131.22 Monday, hitting a record after Nvidia’s $2 billion investment and renewed optimism over Amazon’s AI chip business. The stock earlier touched $135.18. Barclays upgraded Marvell and raised its price target to $150, citing surging demand for optical products in AI data centers. Nvidia and Marvell plan to link custom chips for Nvidia’s NVLink Fusion platform.
Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

13 April 2026
Intel shares climbed $2.09 to $64.47 by late morning Monday, extending a rally that has added over $100 billion in value across eight sessions. The surge follows a raised price target, new deals with Google and Elon Musk’s Terafab, and Intel’s $14.2 billion buyback of Apollo’s Fab 34 stake. The stock is up 69% in 2026 after an 84% gain last year. Intel reports first-quarter results April 23.
Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

13 April 2026
Nebius Group shares climbed 7.4% to $155.74 by midday Monday after Bank of America raised its price target to $175, despite Freedom Capital Markets downgrading the stock to Hold. The Amsterdam-based AI infrastructure firm recently secured a five-year deal with Meta worth up to $27 billion and holds over $40 billion in supply contracts with Microsoft and Meta. Nebius also closed $4.34 billion in convertible debt and sold $2 billion in warrants to Nvidia.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

13 April 2026
Salesforce faced renewed attention after reports of stake reductions by Choreo LLC and Sumitomo Mitsui Trust Group, based on SEC filings from January that reflected year-end positions. Choreo held 27,733 shares and Sumitomo Mitsui 2,478,864 shares as of December 31. The reported cuts amounted to about 35% and 8.6%, respectively. Salesforce shares rose 3.4% Monday, while broader software stocks remain down for the year.
Go toTop